Life Sciences
Balanced CEO Katie Reed talks about what the company has learned since it launched out of beta in November regarding older adults and virtual workouts.
Also: Rupa Health raised $20 million for its lab test platform, and CancerIQ scooped up $14 million in Series B funding.
HIMSS22
UMPC's chief pharmacy officer Chronis Manolis discusses the future of pharmacies ahead of HIMSS22.
Grace Cordovano, a patient advocate, speaks about how telehealth and virtual care make it easier for chronically ill patients to live fuller, more satisfying lives.
The agreement also allows the companies to develop new or improved tools for Dario's chronic condition management platform.
Preliminary data from the women's health study shows individuals with PCOS are more likely to have Type 2 diabetes and obesity than those without the condition.
Automata aims to scale capacities for life scientists.
The lab, which works with AstraZeneca, Merck, Pfizer, Israel Biotech Fund, Teva Pharmaceuticals, and Amazon Web Services, is currently accepting applicants for its new challenge.
The healthcare professional networking and data company said the deal will give its users access to the latest research in biology and medicine.
The company is focusing on its expansion across Asia and the UK.